Western blot analysis showed that in contrast to Bcl-2, expression of Bcl-XL was markedly increased in breast cancer tissues compared to normal; six out of seven patients showed upregulated expression pattern of Bcl-XL (Figure 2A). The gene discussed is BCL2L1; the disease is breast carcinoma.